Where does Iradimed Corporation rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Iradimed Corporation ranks #26,608 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Iradimed Corporation hold?

Iradimed Corporation holds 10 US utility patents granted between 2018 and 2025, spanning 7 technology areas.

What is Iradimed Corporation's Innovation Score?

Iradimed Corporation has an Innovation Score of 32.6 out of 100 (42nd percentile of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

Is Iradimed Corporation's patent grant rate increasing or decreasing?

Iradimed Corporation's recent grant velocity is +150% compared to the prior five-year period (grant years, not application filing dates). This indicates accelerating grant output.

What does claim depth mean for Iradimed Corporation's patents?

Iradimed Corporation's patents average 17.5 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Iradimed Corporation patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView US Corporation

Iradimed Corporation

Q: What technology areas does Iradimed Corporation focus on?

Iradimed Corporation's top technology area is A61M (Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor) with 8 patents. Grants appear in 7 CPC subclasses total.

USPTO PatentsView assignee record - 10 granted patents across 7 technology areas, recorded in grant years 2018–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61M (Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Iradimed ranks #26,608 of 49,997 tracked US assignees by granted-patent volume, with 10 patents across 7 technology areas.

#26,608
of 49,997 US assignees by volume: 42nd percentile
by Innovation Score (32.6/100): 17.5
avg claims per patent: +150%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R26608 · US Corporation #26,608 · 10 grants

GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-RICH · TYPE-USCORP · VEL-SURGE · BOOK-FULL

GRANTS-MICRO 10 grants
MID-PACK #26,608/49,997
PHOTO-FINISH Invectys
CPC-NARROW A61M · 7 areas
INNOV-THIN 32.6/100
CLAIMS-RICH 17.5 claims/avg
TYPE-USCORP US Corporation
VEL-SURGE +150% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Invectys (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

Qualcomm Incorporated · highest

85
Iradimed · this assignee

33
3D Lighting… · lowest

7

What this shows Iradimed's Innovation Score is 32.6/100 (42nd percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Where Iradimed's grants concentrate

Iradimed Corporation is a focused PatentsView assignee: 7 CPC subclasses with 80% of grants classified under A61M (Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor). Peak complete grant year is 2018 (2 grants) versus a trough of 1 in 2021. By volume, Iradimed sits between Invectys and J-quad Dynamics Inc..

Iradimed's three-year grant acceleration

Iradimed Corporation shows 2 grants in 2022–2024 against only 3 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Invectys

10
Iontra

10
Ipass

10
Ipsen

10
Iron Mountain Inc…

10
Iwis antriebssyst…

10
J & J Solutions

10
J-quad Dynamics

10
Iradimed ◀

10

What this shows Iradimed holds 10 patents at rank #26,609, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Iradimed

By rank, the assignees closest to #26,609 in granted patent volume.

Leaders in A61M (Devices FOR Introducing Media Into)

Other assignees with the most granted patents in Iradimed's primary technology class.

Iradimed's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

33 42nd percentile higher than 42% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2018–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2018–2019 baseline. Full figures in the table below.

View data table

Iradimed Corporation patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2018	2	20.0%
2020	2	20.0%
2021	1	10.0%
2022	2	20.0%
2025partial year	3	30.0%

Which technologies does Iradimed Corporation patent most?

A61M - Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor 8

G16H - Healthcare Informatics, i.e. Information AND Communication Technology [ICT] Specially Adapted FOR THE Handling OR Processing OF Medical OR Healthcare Data 5

F04B - Positive-displacement Machines FOR LIQUIDS; Pumps 4

G01R - Measuring Electric VARIABLES; Measuring Magnetic Variables 1

G01V - GEOPHYSICS; Gravitational MEASUREMENTS; Detecting Masses OR OBJECTS; Tags 1

G01P - Measuring Linear OR Angular Speed, Acceleration, Deceleration, OR SHOCK; Indicating Presence, Absence, OR Direction, OF Movement 1

A61B - DIAGNOSIS; SURGERY; Identification 1

Top 7 of 7 technology areas

Where it ranks

Overall rank by patents

#26,608

of 49,997 tracked assignees

Innovation Score

32.6 out of 100

View all rankings →

Data Source

USPTO PatentsView, US granted patents 2015–2025

How is Innovation Score calculated?

What to do with this data

Iradimed Corporation's patent record in context - here's where to go next.

Iradimed Corporation's lead technology class is A61M (Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor), 80% of its portfolio - see every assignee active in that class. Explore A61M
Ranked #26,608 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Iradimed Corporation against Invectys, an assignee filing at a similar volume. Compare portfolios
Innovation Score of 32.6/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.